SeaStar Medical (ICU) Stock Price, News & Analysis

Company Overview

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

Key Stats

• Today's Range: $1.72 to $1.85
• 50-Day Range: $1.57 to $2.28
• 52-Week Range: $1.50 to $42.92
• Volume: 163,349 shs
• Average Volume: 580,094 shs
• Market Capitalization: $7.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SeaStar Medical Stock Analysis - MarketRank™

SeaStar Medical scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for SeaStar Medical.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of SeaStar Medical is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of SeaStar Medical is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.37% of the float of SeaStar Medical has been sold short.

Short Interest Ratio / Days to Cover

SeaStar Medical has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SeaStar Medical has recently decreased by 11.16%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SeaStar Medical does not currently pay a dividend.

Dividend Growth

SeaStar Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

5.37% of the float of SeaStar Medical has been sold short.

Short Interest Ratio / Days to Cover

SeaStar Medical has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SeaStar Medical has recently decreased by 11.16%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.5 / 5
• News Sentiment: N/A

News Sentiment

SeaStar Medical has a news sentiment score of -0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for SeaStar Medical this week, compared to 4 articles on an average week.

Search Interest

2 people have searched for ICU on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, SeaStar Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 2.10% of the stock of SeaStar Medical is held by insiders.

Percentage Held by Institutions

Only 1.69% of the stock of SeaStar Medical is held by institutions.

ICU Stock Analysis - Frequently Asked Questions

How have ICU shares performed this year?

SeaStar Medical's stock was trading at $1.94 at the beginning of the year. Since then, ICU stock has decreased by 9.8% and is now trading at $1.75.
View the best growth stocks for 2025 here.

How were SeaStar Medical's earnings last quarter?

SeaStar Medical Holding Co. (NASDAQ:ICU) posted its earnings results on Tuesday, August, 13th. The company reported ($1.03) EPS for the quarter, topping the consensus estimate of ($1.41) by $0.38.

When did SeaStar Medical's stock split?

Shares of SeaStar Medical reverse split on the morning of Monday, June 10th 2024. The 1-25 reverse split was announced on Monday, June 10th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 10th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Who are SeaStar Medical's major shareholders?

Top institutional investors of SeaStar Medical include Geode Capital Management LLC (1.02%). Insiders that own company stock include Kevin Chung, Heel Kenneth Van and Richard D Russell.
View institutional ownership trends.

How do I buy shares of SeaStar Medical?

Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of SeaStar Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SeaStar Medical investors own include Meta Platforms (META), Pfizer (PFE), Energy Transfer (ET), JPMorgan Chase & Co. (JPM), Kinder Morgan (KMI) and Visa (V).

Company Calendar

• Last Earnings: 8/13/2024
• Today: 2/22/2025
• Next Earnings (Estimated): 4/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:ICU
• CUSIP: N/A
• CIK: 1831868
• Web: seastarmedical.com
• Phone: 844-427-8100
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($11.63)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-26,230,000.00
• Net Margins: N/A
• Pretax Margin: -43,926.47%
• Return on Equity: N/A
• Return on Assets: -627.49%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.54
• Quick Ratio: 0.54

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($6.29) per share
• Price / Book: -0.28

Miscellaneous

• Outstanding Shares: 4,460,000
• Free Float: 4,369,000
• Market Cap: $7.81 million
• Optionable: Not Optionable
• Beta: -1.02